Claude LeDuc
Präsident bei Axcelon Dermacare, Inc.
Profil
Claude LeDuc is currently the President & Chief Operating Officer at Axcelon Dermacare, Inc. He previously served as the President & Chief Executive Officer at BioSyntech, Inc. from 2004 to 2008.
He was also the President, Chief Executive Officer & Director at MRM Proteomics, Inc. Additionally, he served as the Director-International Markets at Genzyme Biosurgery Corp.
and as the Manager-Regional Marketing & Sales at EMD Serono, Inc. Mr. LeDuc obtained his undergraduate degree from the University of Montréal.
Aktive Positionen von Claude LeDuc
| Unternehmen | Position | Beginn |
|---|---|---|
| Axcelon Dermacare, Inc. | Präsident | - |
Ehemalige bekannte Positionen von Claude LeDuc
| Unternehmen | Position | Ende |
|---|---|---|
| CHITOGENX INC. | Vorstandsvorsitzender | 15.03.2022 |
| BIOSYNTECH, INC. | Vorstandsvorsitzender | 31.12.2008 |
MRM Proteomics, Inc.
 MRM Proteomics, Inc. BiotechnologyHealth Technology MRM Proteomics, Inc. provides proteomics services. Its products include PeptiQuant, protein quant and quality control kits. The firm offers PeptiQuant protein quantitation, protein characterization and tissue imaging services. The company was founded in 2010 and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Vertrieb & Marketing | - |
Genzyme Biosurgery Corp.
 Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Claude LeDuc
| University of Montréal | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOSYNTECH, INC. | Health Technology |
| CHITOGENX INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Genzyme Biosurgery Corp.
Genzyme Biosurgery Corp. BiotechnologyHealth Technology Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Axcelon Dermacare, Inc. | |
MRM Proteomics, Inc.
MRM Proteomics, Inc. BiotechnologyHealth Technology MRM Proteomics, Inc. provides proteomics services. Its products include PeptiQuant, protein quant and quality control kits. The firm offers PeptiQuant protein quantitation, protein characterization and tissue imaging services. The company was founded in 2010 and is headquartered in Montreal, Canada. | Health Technology |
